Doxycycline is NOT recommended for treatment of Crohn's disease
Antibiotics, including doxycycline, should not be used as induction or maintenance therapy for moderate to severe Crohn's disease 1. The most recent 2025 British Society of Gastroenterology guidelines explicitly state they "cannot support their use" based on high-certainty evidence showing only small or trivial benefits.
Why Antibiotics Are Not Recommended
The evidence against routine antibiotic use in Crohn's disease is compelling:
- Minimal efficacy: While antibiotics show a statistically significant effect for induction (55% vs 65% failure rate compared to placebo), the clinical benefit is small and likely trivial 1
- No maintenance benefit: The effect on preventing relapse is uncertain, with low-certainty evidence showing no clear advantage 1
- No specific antibiotic has been adequately studied: Neither doxycycline nor any other individual agent has sufficient evidence to support its use 1
Critical Safety Concern: Doxycycline May Worsen IBD
There is concerning evidence that doxycycline specifically may increase the risk of developing or worsening inflammatory bowel disease:
- A large UK cohort study found doxycycline had the highest hazard ratio (2.25) for developing Crohn's disease among tetracycline antibiotics 2
- Recent Danish nationwide data showed quinolones and beta-lactams significantly increased flare-up risk (OR 3.04-3.82 for quinolones) 3
- Antibiotic exposure in general is associated with increased IBD risk, particularly within 1-2 years of use 4
Important Exceptions
The guideline explicitly notes this recommendation does not apply to:
- Intra-abdominal sepsis
- Perianal sepsis/fistulizing disease
- Documented bacterial infections requiring treatment 1
Practical Guidance
If you're considering doxycycline for a patient with Crohn's disease:
- For Crohn's disease itself: Do not use. Choose evidence-based therapies (biologics, small molecules, corticosteroids for acute flares)
- For a separate bacterial infection: Use only when clearly indicated, recognizing it may trigger a disease flare 3
- Consider alternative antibiotics: If antibiotics are absolutely necessary for a non-IBD indication, avoid doxycycline given its particularly strong association with Crohn's disease development 2
The FDA label for doxycycline does not list Crohn's disease as a contraindication, but warns about gastrointestinal effects including C. difficile-associated diarrhea, which could complicate IBD management 5.